Menu
Introduction The rising tide of antimicrobial resistance AMR has made the development of novel antibacterial agents more critical than ever. Against this backdrop, the introduction of Indias first indigenously developed
Interferons can explain why males & older people are more vulnerable to #COVID19. (Nature, 2 Nov 2020) Main causes for vulnerability: IFN-1 deficiencies and autoantibodies to IFN-1. [A] First, what
If a household member gets #COVID19, what’s your chance of getting infected from him? Latest report from CDC (30 Oct 2020) 101 index patients and 191 household members were enrolled
Death rates have dropped significantly in critically ill #COVID19 patients. [1] Survival rates have improved with medical advances and less crowded hospitals. England study of 15,000 patients showed that survival
Lancet Respiratory Medicine, 29 Oct 2020 [1] Surface transmission is unlikely to be a major route of transmission, as although SARS-CoV-2 can persist for days on inanimate surfaces, attempts to
[1] Chronic obstructive pulmonary disease (COPD) is a progressive, inflammatory lung disease with few available disease-modifying therapies. [2] Acute exacerbations of COPD (AECOPD) increase morbidity and mortality, and their occurrence
[1] First 5 to 8 seconds after coughing are critical: During this time the exhaled droplets remain suspended in the air and can spread of the disease. After that time,
[1] Vaccine-associated enhanced disease (VAED) is an immune response to a vaccine that is ‘causally linked’ to a higher risk of adverse outcomes upon infection compared to infection without prior
1] Neuraminidase (NA) protein found on mumps virus has some similarities with the Spike protein of #sarscov2 2] The universal mumps vaccine and MMR vaccine, produce anti-NA antibodies. 3] These
[1] Successful clearance of SARS-CoV-2 cannot guarantee the complete remission of symptoms and that severe symptoms can occur in the absence of virus. #SARSCoV2 [2] Two possible mechanisms: #COVID19 a.
